Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant glycoprotein gp350 of Epstein-Barr virus

EU orphan designation number: EU/3/02/118   
Active ingredient: Recombinant glycoprotein gp350 of Epstein-Barr virus
Indication: Prevention of post transplantation lympho-proliferative disorders
Sponsor: Henogen S.A.
12 rue des Professeurs Jeener et Brachet, B-6041 Gosselies (Charleroi), Belgique

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2002 Centralised Orphan - Designation EMEA/OD/043/01 (2002)4122 of 22/10/2002